Search

Dr. Blinderman is a national leader in supportive care.

… Wednesday, November 1, 2023 Craig D. Blinderman, MD has been appointed Chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center (MSK). Dr. Blinderman is a national leader in supportive care who comes to MSK from Columbia University Medical Center/NewYork-Presbyterian Hospital, where

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.

… Monday, February 19, 2024 By the summer of 2022, Roberto Romero was running out of options to treat the melanoma he’d been coping with since 2015. He’d already had several surgeries and many rounds of drug treatment. But the cancer — which started as a dark spot under a toenail — continued to grow and

Learn whether eating soy products causes cancer.

… Wednesday, July 27, 2022 “Does eating soy cause breast cancer?” It’s a question regularly posed to Julia Brockway-Marchello , a Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist at MSK Nassau in Uniondale, New York. But her answer is a clear and decisive no. “Soy is actually helpful

Surprise! It has to do with metabolism.

… Wednesday, September 18, 2019 Summary The most commonly mutated gene in cancer,  p53, works by shifting cell metabolism in a way that alters a cell’s identity, researchers at the Sloan Kettering Institute have discovered. More than 50% of all cancers contain a mutation in the p53 gene. The protein made

Viviane Tabar, MD, has been named the new Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Tabar has been a vital faculty member at MSK for more than 15 years and is currently the Theresa C. Feng Chair for Neurosurgical Oncology and the Vice Chair for Neurosurgical Research and Education.

… Wednesday, December 6, 2017 Viviane Tabar, MD , has been named the new Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Tabar has been a vital faculty member at MSK for more than 15 years and is currently the Theresa C. Feng Chair for Neurosurgical Oncology

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Friday, October 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Luis Alberto Diaz, Jr. Appointed to the National Cancer Advisory Board by President Biden Luis Alberto Diaz, Jr. Luis Alberto Diaz, Jr., MD , Head of the Division of Solid Tumor Oncology

Memorial Sloan Kettering Cancer Center (MSK) today announced that Shelly Anderson, MPM, will join the institution as the inaugural Hospital President on September 25. Anderson joins MSK from Brigham and Women’s Hospital (BWH) in Boston, where she has been a member of the executive leadership team since 2011, most recently serving as Executive Vice President and Chief Operating Officer.

… Monday, June 26, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced that Shelly Anderson, MPM, will join the institution as the inaugural Hospital President on September 25. Anderson joins MSK from Brigham and Women’s Hospital (BWH) in Boston, where she has been a member of the executive

The event featured scientific talks from leading women in science, including winners of this year’s Kravis WISE fellowships.

… Friday, March 19, 2021 On March 17, 2021, scientists from around the world tuned in to watch the 2nd Annual Kravis WISE Symposium , a series of scientific talks sponsored by the Marie-Josée Kravis Women in Science Endeavor (WISE) at Memorial Sloan Kettering. Launched in 2020, Kravis WISE is devoted to

The Tri-Institutional Stem Cell Initiative, comprised of three leading New York City biomedical research institutions -- Memorial Sloan Kettering Cancer Center, The Rockefeller University, and Weill Medical College of Cornell University -- has announced the first wave of stem cell research projects to be funded through a $50 million gift from The Starr Foundation.

… Monday, July 31, 2006 First Research Projects to be Funded under the Tri-Institutional Stem Cell Initiative The Tri-Institutional Stem Cell Initiative , comprised of three leading New York City biomedical research institutions — Memorial Sloan Kettering Cancer Center, The Rockefeller University, and

A collaborative team from MSK has uncovered important new findings that explain why ovarian cancer does not respond to immunotherapy.

… Wednesday, December 14, 2022 A team at Memorial Sloan Kettering Cancer Center (MSK) has uncovered several mechanisms of immune escape that can help explain why ovarian cancers have been resistant to immunotherapy to date. The researchers found that ovarian cancer is even more complex than previously